US Stock MarketDetailed Quotes

RPRX Royalty Pharma

Watchlist
  • 24.920
  • +0.640+2.64%
Close Dec 20 16:00 ET
  • 25.010
  • +0.090+0.36%
Post 20:01 ET
11.07BMarket Cap9.81P/E (TTM)

Royalty Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Royalty Pharma Q3 2024 Earnings Date

Currency：USDNov 6, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
731.83M
564.69M
-167.14M
Miss Est.
+36.46%
+5.29%
-22.84%
EPS
0
1.21
+1.21
Beat Est.
--
+656.25%
--
Analyst Rating
Strong Buy

Dec 4, 2024

Royalty Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 622.434M--
Nov 6, 20242024/Q3565.000M / 731.832M--
Aug 8, 20242024/Q2537.000M / 645.290M--
May 9, 20242024/Q1568.000M / 709.445M--
Feb 15, 20242023/Q4596.000M / 674.541M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 622.434M--
Nov 6, 20242024/Q3565.000M / 731.832M--
Aug 8, 20242024/Q2537.000M / 645.290M--
May 9, 20242024/Q1568.000M / 709.445M--
Feb 15, 20242023/Q4596.000M / 674.541M--

Unlock Free Earnings Estimates

Royalty Pharma Earnings Reports

  • Royalty Pharma | 10-Q: Q3 2024 Earnings Report

    Nov 6 09:27 ET

  • Royalty Pharma | 8-K: ROYALTY PHARMA REPORTS THIRD QUARTER 2024 RESULTS

    Nov 6 07:37 ET

  • Royalty Pharma | 10-Q: Q2 2024 Earnings Report

    Aug 8 09:04 ET

  • Royalty Pharma | 8-K: ROYALTY PHARMA REPORTS SECOND QUARTER 2024 RESULTS

    Aug 8 07:24 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 4, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data